These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7528538)

  • 1. Aprotinin therapy for insertion of ventricular assist devices for staged heart transplantation.
    Pae WE; Aufiero TX; Weldner PW; Miller CA; Pierce WS
    J Heart Lung Transplant; 1994; 13(5):811-6. PubMed ID: 7528538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the role of aprotinin in heart transplantation.
    Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V
    Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation.
    Goldstein DJ; Oz MC; Smith CR; Friedlander JP; De Rosa CM; Mongero LB; Delphin E
    Ann Thorac Surg; 1996 Feb; 61(2):692-5. PubMed ID: 8572789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of aprotinin in pediatric lung transplantation.
    Jaquiss RD; Huddleston CB; Spray TL
    J Heart Lung Transplant; 1995; 14(2):302-7. PubMed ID: 7540042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eleven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; McBride LR; Miller LW; Swartz MT
    J Heart Lung Transplant; 1994; 13(5):803-10. PubMed ID: 7803421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose aprotinin in cardiac operations.
    Haddad R; Kesrouani C; Nasr W
    J Med Liban; 2000; 48(3):157-60. PubMed ID: 11268570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
    Bidstrup BP; Underwood SR; Sapsford RN; Streets EM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):147-52; discussion 153. PubMed ID: 7678314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden does not affect bleeding in aprotinin recipients after cardiopulmonary bypass.
    Boehm J; Grammer JB; Lehnert F; Dietrich W; Wagenpfeil S; Wildhirt SM; Wottke M; Braun S; Lange R; Bauernschmitt R
    Anesthesiology; 2007 Apr; 106(4):681-6. PubMed ID: 17413905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
    Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
    Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
    Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.